Molecular Immune Pathogenesis and Diagnosis of COVID-19

Xiaowei Li,Manman Geng,Yizhao Peng,Liesu Meng,Shemin Lu
DOI: https://doi.org/10.1016/j.jpha.2020.03.001
IF: 14.026
2020-01-01
Journal of Pharmaceutical Analysis
Abstract:Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.
What problem does this paper attempt to address?